Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,278 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

NCT01248884

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Santo Domingo, Dominican Republic
  • GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
View all 16 locations
View Trial Details
Completed

Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

NCT01090453

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
Locations
  • GSK Investigational Site Vancouver, British Columbia, Canada
  • GSK Investigational Site Winnipeg, Manitoba, Canada
  • GSK Investigational Site Hamilton, Ontario, Canada
  • GSK Investigational Site Aix-en-Provence, France
View all 34 locations
View Trial Details
Completed

Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine

NCT00805389

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Ghent, Belgium
  • GSK Investigational Site La Louvière, Belgium
  • GSK Investigational Site Wilrijk, Belgium
View all 14 locations
View Trial Details
Completed

Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination

NCT00984139

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Pforzheim, Baden-Wurttemberg, Germany
View all 24 locations
View Trial Details
Completed

Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

NCT00197184

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations
  • GSK Investigational Site North Adelaide, South Australia, Australia
  • GSK Investigational Site Carlton, Victoria, Australia
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Barcelona, Spain
View Trial Details
Completed

Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder

NCT01847430

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Tuttlingen, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bindlach, Bavaria, Germany
  • GSK Investigational Site Kirchheim, Bavaria, Germany
View Trial Details
Completed

Engagement to Care South Africa

NCT02417233

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • Moses Kotane Sub-district clinics Mabeskraal, Northwest, South Africa
  • Rustenburg Sub-district clinics Rustenburg, Northwest, South Africa
View Trial Details
Completed

Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children

NCT01138098

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Banská Bystrica, Slovakia
  • GSK Investigational Site Dolný Kubín, Slovakia
  • GSK Investigational Site Dubnica nad Váhom, Slovakia
  • GSK Investigational Site Martin, Slovakia
View Trial Details
Completed

Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.

NCT00519649

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations
  • GSK Investigational Site Birkenfeld, Baden-Wurttemberg, Germany
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Heidelberg, Baden-Wurttemberg, Germany
  • GSK Investigational Site Karlsruhe, Baden-Wurttemberg, Germany
View all 35 locations
View Trial Details
Completed

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

NCT01721109

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • East Bay AIDS Center Medical Group Oakland, California, United States
  • University of South Florida - Department of Pediatrics Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • New York University School of Medicine New York, United States
View all 18 locations
View Trial Details

Related conditions